我国男性勃起障碍诊断标准有望标准化

2019-05-26 叶佳琪 黄辛 科学网

5月25日,在上海交通大学医学院附属仁济医院举行的第14届仁济男科论坛暨第二届中美欧男性健康高峰会议上,上海市男科学研究所常务副所长卢慕峻透露,我国男性勃起障碍(ED)诊断标准有望进一步标准化。与会专家呼吁,控制体重、切勿熬夜、戒烟戒酒、养成良好的生活习惯和饮食习惯,定期进行有氧锻炼,可有效防止ED的发生。


5月25日,在上海交通大学医学院附属仁济医院举行的第14届仁济男科论坛暨第二届中美欧男性健康高峰会议上,上海市男科学研究所常务副所长卢慕峻透露,我国男性勃起障碍(ED)诊断标准有望进一步标准化。与会专家呼吁,控制体重、切勿熬夜、戒烟戒酒、养成良好的生活习惯和饮食习惯,定期进行有氧锻炼,可有效防止ED的发生。

据大会主旨报告发言人、北美性医学前任主席王润教授介绍,随着生活工作压力加大、老龄化进程、生活饮食结构改变等因素,男性勃起功能(ED)的发病率正逐年升高,国内外40岁以上男性ED是严重影响男性健康的常见疾病。ED的发病往往伴随肥胖、高血压、高血脂、糖尿病等,是男性亚健康或者潜在心脑血管疾病的一种预警,被视为男性健康的风向标。如果不及时干预,2-3年后往往会造成不可逆的血管粥样病变和狭窄,进一步会引起心肌缺血、心绞痛、肾功能下降甚至心梗、脑梗等恶性事件。

大会主旨报告发言人、中国性学会会长姜辉教授介绍,男性勃起功能(ED)诊断主要依靠性激素检查、性功能量表、夜间勃起功能监测(NPTR)及视听刺激下勃起测定(AVSS)等方法,虽然欧洲及美国都有各自的NPTR标准,但国内的诊断标准仍有待于进一步明确和探讨。

据卢慕峻教授介绍,目前AVSS在国内已普遍成为一种门诊快速诊断ED的重要方法,但各中心检测方式和参考标准不一。仁济医院男科暨上海市男科学研究所作为牵头单位,组织全国多家单位开展临床联合研究,期望尽快规范AVSS检测流程和制定参考标准,本次会议将结合前期研究结果,讨论和制定适应适合我国公民的阴茎勃起功能参数的标准体系,该标准体系主要涉及我国各年龄段男性健康人的阴茎勃起的时间、硬度和周径等参数。

“目前国内外针对男性勃起功能(ED)障碍的治疗方法包括药物治疗、海绵体药物注射、真空负压吸引、低能量冲击波(Li-SWT)和假体手术”,“个性化治疗是保证ED治疗效果的关键。对于临床上严重男性勃起功能患者,例如重度静脉漏ED、糖尿病引起的严重ED、骨盆骨折后、盆腔手术后神经性ED以及一、二线治疗无效的ED患者,阴茎假体手术目前仍然是临床治疗最有效的金标准。”卢慕峻表示, 作为我国最早开展男科工作的临床机构之一,仁济医院在2001年成立上海市男科研究所,具备包括男性不育、性功能障碍、男性生殖器整形及尿道重建、男性生殖肿瘤及微创手术等亚专业,常规开展包括阴茎假体植入术、显微镜下输精管道重建术等在内的所有男科手术,年门诊量约10万人次。

据悉,本次会议的主题是“男性勃起功能(ED)康复和修复重建”,国内外男性健康领域的100余位知名专家到会研讨,讨论和制定适应国人的阴茎勃起功能参数的标准体系,就男性勃起功能障碍及男性外生殖器整形修复的诊治最新进展进行专题研讨。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771175, encodeId=1a6d1e71175a1, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Fri May 01 01:04:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946619, encodeId=2e191946619db, content=<a href='/topic/show?id=aa03334288a' target=_blank style='color:#2F92EE;'>#勃起障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33428, encryptionId=aa03334288a, topicName=勃起障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 18 06:04:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758855, encodeId=54351e5885595, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Fri Nov 15 18:04:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385026, encodeId=e9641385026eb, content=<a href='/topic/show?id=354691625f1' target=_blank style='color:#2F92EE;'>#诊断标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91625, encryptionId=354691625f1, topicName=诊断标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue May 28 14:04:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366836, encodeId=13eb366836d7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sun May 26 23:20:54 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
    2020-05-01 habb
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771175, encodeId=1a6d1e71175a1, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Fri May 01 01:04:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946619, encodeId=2e191946619db, content=<a href='/topic/show?id=aa03334288a' target=_blank style='color:#2F92EE;'>#勃起障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33428, encryptionId=aa03334288a, topicName=勃起障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 18 06:04:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758855, encodeId=54351e5885595, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Fri Nov 15 18:04:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385026, encodeId=e9641385026eb, content=<a href='/topic/show?id=354691625f1' target=_blank style='color:#2F92EE;'>#诊断标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91625, encryptionId=354691625f1, topicName=诊断标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue May 28 14:04:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366836, encodeId=13eb366836d7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sun May 26 23:20:54 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771175, encodeId=1a6d1e71175a1, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Fri May 01 01:04:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946619, encodeId=2e191946619db, content=<a href='/topic/show?id=aa03334288a' target=_blank style='color:#2F92EE;'>#勃起障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33428, encryptionId=aa03334288a, topicName=勃起障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 18 06:04:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758855, encodeId=54351e5885595, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Fri Nov 15 18:04:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385026, encodeId=e9641385026eb, content=<a href='/topic/show?id=354691625f1' target=_blank style='color:#2F92EE;'>#诊断标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91625, encryptionId=354691625f1, topicName=诊断标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue May 28 14:04:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366836, encodeId=13eb366836d7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sun May 26 23:20:54 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771175, encodeId=1a6d1e71175a1, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Fri May 01 01:04:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946619, encodeId=2e191946619db, content=<a href='/topic/show?id=aa03334288a' target=_blank style='color:#2F92EE;'>#勃起障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33428, encryptionId=aa03334288a, topicName=勃起障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 18 06:04:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758855, encodeId=54351e5885595, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Fri Nov 15 18:04:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385026, encodeId=e9641385026eb, content=<a href='/topic/show?id=354691625f1' target=_blank style='color:#2F92EE;'>#诊断标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91625, encryptionId=354691625f1, topicName=诊断标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue May 28 14:04:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366836, encodeId=13eb366836d7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sun May 26 23:20:54 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1771175, encodeId=1a6d1e71175a1, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Fri May 01 01:04:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946619, encodeId=2e191946619db, content=<a href='/topic/show?id=aa03334288a' target=_blank style='color:#2F92EE;'>#勃起障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33428, encryptionId=aa03334288a, topicName=勃起障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 18 06:04:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758855, encodeId=54351e5885595, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Fri Nov 15 18:04:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385026, encodeId=e9641385026eb, content=<a href='/topic/show?id=354691625f1' target=_blank style='color:#2F92EE;'>#诊断标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91625, encryptionId=354691625f1, topicName=诊断标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue May 28 14:04:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366836, encodeId=13eb366836d7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sun May 26 23:20:54 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
    2019-05-26 orangesking

    看看

    0

相关资讯

男性乳腺包裹性乳头状癌超声表现1例

患者男,52岁。发现左乳无痛性肿块1年,进行性增大1个月。专科检查:双乳对称,双乳头无凹陷,表面皮肤无红肿、破溃,无明显橘皮样改变。左乳内上象限乳晕旁可及大小约2.5 cm×2.0 cm肿块,质中,边界清,活动度尚可,与周围组织无粘连,无压痛。

Am J Clin Nutr:警惕!多吃动物性蛋白或与人群死亡风险增加直接相关

富含动物性蛋白的饮食(尤其是肉类)对机体健康并没有好处,近日,来自东芬兰大学的科学家们通过研究提供了一定的证据,在20年的随访研究中他们发现,相比在饮食蛋白质方面更加均衡的男性而言,更加偏爱动物蛋白而不喜欢植物蛋白饮食方式的男性死亡风险或许更高,相关研究结果刊登于国际杂志The American Journal of Clinical Nutrition上。

你要的男性更佳生育年龄来了!速看

据研究结果表明,男性最佳生育年龄为25~34岁。

Heart:女性和男性左心室舒张功能纵向变化的危险因素

由此可见,男性吸烟和男性代谢因素(糖尿病和体重指数)与LVDF参数的纵向变化之间存在较密切的有害关联。HDL与其之间的良好关联主要在女性中观察到。该研究首次评估了女性和男性持续LVDF参数随时间变化相关的危险因素,并为进一步的医学研究提供了新的假设。

比起女性,男人更应该打HPV疫苗!

HPV疫苗自上市以来就一直受到大家的关注,最近一起男性想要接种疫苗却被拒绝的事件,又成了全民热议的话题。

男性口服避孕药通过了初步安全测试

上周,美国FDA批准了史上第一款专治女性产后抑郁的新药投入临床使用,在美国乃至中国的潜在用户群体中引发了强烈反响。据说,该药物几期实验的效果都十分理想,大概唯一的遗憾就是非常之贵——一个疗程需要34000美元。